Upadacitinib Impurity 37 | CAS 1145-81-9 - Request Quote
Upadacitinib Impurity 37
| SZ CAT No: | SZ-U005042 |
| CAS No | 1145-81-9 |
| Mol.F. | C12H15NO4 |
| Mol.Wt. | 237.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Upadacitinib Impurity 37 is chemically Ethyl ((benzyloxy)carbonyl)glycinate. Upadacitinib Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1145-81-9
Purchase 1145-81-9
Order 1145-81-9
Enquire 1145-81-9
price of 1145-81-9
1145-81-9 Supplier
1145-81-9 Manufacturer
1145-81-9 Exporter
buy high quality Upadacitinib Impurity 37
Purchase Upadacitinib Impurity 37
Upadacitinib Impurity 37 suppliers
Upadacitinib Impurity 37 manufacturers
Upadacitinib Impurity 37 price
Order Upadacitinib Impurity 37
Enquire Upadacitinib Impurity 37
Upadacitinib Impurity 37 cost
Upadacitinib Impurity 37 Supplier
Upadacitinib Impurity 37 Distributor
Upadacitinib Impurity 37 for Method Validation
Upadacitinib Reference Standard
Upadacitinib Impurity 37 for ANDA Filing
Upadacitinib Impurity 37 for Forced Degradation Studies
Upadacitinib Impurity 37 Identification Standards
Upadacitinib Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.